Health and Pharmaceuticals

Pfizer's Q1 profit tops forecasts

by AP
0 Comments
Drug maker posts profit of $US.2.38 billion for the quarter.

Blackmores sees record profit

by AAP
0 Comments
Vitamin and supplements maker Blackmores buoyed by strong sales in Asia.

Healthcare REIT raising $52 million

0 Comments
Generation Healthcare REIT raises funds for acquisition of three aged care properties.

PBS review may generate $3bn in savings

by AAP
0 Comments
Health minister tips changes to Pharmaceutical Benefits Scheme, could save $1bn-$3bn.

Mylan boosts offer for Perrigo

by AFP
0 Comments
Bid comes on the heals of Israel's Teva attempt to lock Mylan up with its own offer.

Exchange rates squeeze ResMed margin

0 Comments
New products boost health device manufacturer's quarterly revenue, while profit little changed.

CSL to begin hunt for new CFO

0 Comments
Company to launch global search to replace Gordon Naylor who will lead new influenza vaccine business.

API bounces back to H1 profit

by AAP
0 Comments
Australian Pharmaceuticals Industries swings back to black on strong Priceline performance.

US drugmaker Mylan fields $31bn bid

by AFP
0 Comments
Unsolicited bid from Israel's Teva Pharmaceutical would create global behemoth.

Novogen taps investors for $30.5m

0 Comments
Biotech group raises funds for growth phase driven by progress on cancer-fighting drugs.

Teva Pharmaceutical considering bid for Mylan

0 Comments
The Israeli generic drug maker still undecided whether to make a run, say sources.

General Electric swings to $US13.6bn loss in Q1

0 Comments
Group takes charge on finance division divestment, earnings narrowly beat expectations.

Prowling Fosun­ eyes Vitaco

Chinese conglomerate's latest target is understood to be Australia’s largest vitamin producer.

J&J posts fall in Q1 profit

0 Comments
Healthcare group pressured by strong US dollar, weaker sales of hepatitis drug.

Inside Apple's ResearchKit

0 Comments
Apple’s latest toolbox offers researchers an off-the-shelf way to design clinical trials that “crowd source” research studies.

Mesoblast soars on Celgene stake

0 Comments
Shares jump after US group buys 4.72% stake in regenerative medicine company for $58.5m.

Novogen surges 40% on drug study

0 Comments
Shares in drug discoverer rocket after second successful cancer study in as many weeks.

US court overturns Cochlear ruling

0 Comments
Decision could allow partial recoup of $US131.2 million damages payment.

Novogen shares surge on drug data

by AAP
0 Comments
Shares in drug discoverer Novogen rally after experimental anti-cancer drug trial.

The promise and challenge of health analytics

0 Comments
Medicine's bold new frontier needs to be more than just about capturing data. We need a rethink in the culture of patient care and new approaches to data ownership and security.

Pages